AzTrials
AzTrials

Upper Trapezius Trigger PointsNCT05415813

Effects of IC With and Without MET on Upper Trapezius Trigger Points

A study testing Ischemic Compression and Ischemic compression with Muscle Energy Technique in people with Upper Trapezius Trigger Points, run by University of Lahore at 1 site in Pakistan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

the aim of the study is to check the effects of ischemic compression with and without muscle energy technique on Pain, Range of motion, and Functional Disability on myofascial trigger points in the upper trapezius. Read more about this study

Who is it for?
Ages 18 to 50 years
Conditions the study is for
Upper Trapezius Trigger Points
What is being tested?
Ischemic Compression and Ischemic compression with Muscle Energy Technique
Could I receive a placebo?
No, everyone receives an active treatment
How many people
76 participants
Where
1 sitePakistan
Study dates
17 Aug 2021to 23 Jun 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 50 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Both gender Aged 18 to 50 years (40)
  • Participants with active myofascial trigger points in the upper trapezius diagnosed by a senior physiotherapist on the basis of Travel and Simon criteria will be randomly allocated into two clinical groups.
  • Taut band having palpable nodule within upper trapezius muscle
  • Pain produced in a specific pattern which is radiating in character when firm pressure is applied on trigger points

Who cannot join

  • Trauma (whiplash injury)
  • Injury to Cervical Spine
  • Cervical Spine surgery
  • Cervical Myelopathy and Radiculopathy
  • Osteoporosis of the cervical spine
  • Cervical myeloma
  • Complex regional pain syndrome
  • Patients with the H/O any Neurological, Rheumatology and other serious medical illnesses.

Trial locations and contacts

1 site in 1 country.

Pakistan1 site
  • University of Sialkot

    Sialkot, Punjab Province

Other trials in Pakistan

About this study

Official title: Effects of Ischemic Compression With and Without Muscle Energy Technique on Pain, Range of Motion and Functional Disability in Patients With Trigger Points in Upper Trapezius; A Randomized Clinical Trial

the aim of the study is to check the effects of ischemic compression with and without muscle energy technique on Pain, Range of motion, and Functional Disability on myofascial trigger points in the upper trapezius. In previous studies, Muscle Energy Technique and Ischemic Compression are compared with different conventional and combined therapy approaches, including most of the techniques used to treat Trigger Points in the upper trapezius. No study has evaluated the effects of ischemic compression with and without muscle energy technique on Pain, Range of motion, and Functional Disability on myofascial trigger points in the upper trapezius. The outcome measures are a Numeric pain rating scale, universal goniometer and neck disability index questionnaire.

Being tested
Ischemic Compression, Ischemic compression with Muscle Energy Technique

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ischemic CompressionOther

    It includes conventional Physical therapy, hot packs (75°C) for 20 minutes, and active stretching exercises for the upper trapezius muscle (slow, 5 repetitions per session, 10-second hold, and 10-second relaxation between two repetitions) as a baseline treatment. For the Ischemic compression, the patient will be in the supine position with the cervical spine in opposite lateral flexion to the treating part so that the upper trapezius muscle fibers were kept in a lengthened position physiotherapist will apply gradually increasing pressure to the Trigger points until the subject perceived the first noticeable pain. At that moment, the pressure will be maintained until the discomfort and/or pain eased by around 50% as perceived by the patient, at which time the pressure will be increased until the discomfort appears again. This process will be maintained for 90 seconds.

  • Ischemic compression with Muscle Energy TechniqueOther

    The Participants will receive all the treatments given to the active comparator group and they will also receive the Muscle Energy Technique treatment in supine position and the practitioner will stabilize the shoulder of the affected side with one hand, while the ear/mastoid area of the affected side will be held by the opposite hand. The head and neck were then bent towards the contralateral side, flexed, and ipsilaterally rotated. The subjects will then shrug the stabilized shoulder towards the ear at a sub-maximal pain-free effort (20% of the available strength). The isometric contraction will be held for 7-10s. This position will be maintained for 30 seconds and repeated three to five times per treatment session. Treatment sessions will be given on alternate days.

Study groups in NCT05415813
Study groupRoleWhat they receive
Ischemic CompressionActive comparatorIschemic Compression will be applied to the upper trapezius trigger points in patients recruited in group 1.
Receives: Other: Ischemic Compression
Ischemic compression and Muscle Energy TechniqueExperimentalischemic compression along with muscle energy technique will be applied to the upper trapezius trigger points in patients allocated to group 2.
Receives: Other: Ischemic compression with Muscle Energy Technique

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change from Baseline in pain on Numeric Pain Rating Scale at week 4

    on a scale of 1 to 10, o means no pain while 10 means worst pain

    Measured: Baseline and week 4

  2. Change from Baseline in Goniometer readings at week 4

    for flexion any value less than 90 degrees indicates limited range of motion, for extension any value less than 70 indicates limited range of motion, for lateral flexion values less than 20 and greater than 45 considered limited, for rotation value less than 90 is considered limited

    Measured: Baseline and week 4

  3. Change from baseline in Neck disability index questionnaire scores at week 4

    on a scale of 0 to 50, 0 indicates no disability and 50 indicates completely disabled

    Measured: Baseline and week 4

Secondary outcomes (3)
  1. Pain on Numeric Pain Rating Scale at week 2

    on a scale of 1 to 10, o means no pain while 10 means worst pain

    Measured: week 2

  2. Goniometer readings at week 2

    Using goniometer, neck ranges of motion will be measured. for flexion any value less than 90 degrees indicates limited range of motion, for extension any value less than 70 indicates limited range of motion, for lateral flexion values less than 20 and greater than 45 considered limited, for rotation value less than 90 is considered limited

    Measured: week 2

  3. Neck disability index questionnaire scores at week 2

    on a scale of 0 to 50, 0 indicates no disability and 50 indicates completely disabled

    Measured: week 2

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jun 2022
  2. Study start17 Aug 2021
  3. Primary completion17 Jun 2022
  4. Study completion23 Jun 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
76 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05415813
Sponsor's protocol ID
IRB-UOL-FAHS/890-II/2021
Status last verified
Apr 2023
First submitted
8 Jun 2022
Last updated
7 Apr 2023
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Ischemic Compression and Ischemic compression with Muscle Energy Technique in people with Upper Trapezius Trigger Points, run by University of Lahore at 1 site in Pakistan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 7 Apr 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Pakistan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change from Baseline in pain on Numeric Pain Rating Scale at week 4 (time frame: Baseline and week 4). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 7 Apr 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in